Skip to content

Prognostic value of obtaining negative vaginal margins by the guidence of frozen-section in cervical cancer

Prognostic value of obtaining negative vaginal margins by the guidence of frozen-section in cervical cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035668
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Experimental group:obtaining negative vaginal margins by the guidence of frozen-section during operation
Control group:Type B/C radical hysterectomy

Sponsors

The Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Clinical diagnosis of cervical cancer (IB1-IIA2); 2) Preoperative pathological diagnosis of cervical squamous cell carcinoma, cervical adenosquamous carcinoma or cervical adenocarcinoma 3) Aged <=65 years; 4) Initial treatment; 5) Subjects volunteer to join the study, sign an informed consent form, have good compliance, and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1) Patients' general condition is poor and severe medical complications are difficult to tolerate surgical treatment; 2) Patients who have previously received pelvic/abdominal radiotherapy or chemotherapy; 3) Patients during pregnancy; 4) Patients with other gynecological malignancies such as ovarian tumors; 5) CT, MRI or PET suggesting extracervix metastasis; 6) Those who are unable or unwilling to sign the informed consent form, and are unable or unwilling to comply with the research requirements.

Design outcomes

Primary

MeasureTime frame
Overall survival and recurrence-free survival;

Contacts

Public ContactHua Keqin

The Obstetrics and Gynecology Hospital of Fudan University

huakeqin@126.com+86 15921515900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026